(3AR,8AR)-(-)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二氧并[4,5-E][1,3,2]二氧磷-6-YL)二甲胺 基本信息
MSDS 用途与合成方法 (3AR,8AR)-(-)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二氧并[4,5-E][1,3,2]二氧磷-6-YL)二甲胺价格(试剂级) 上下游产品信息
| 中文名称 | (3AR,8AR)-(-)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二氧并[4,5-E][1,3,2]二氧磷-6-YL)二甲胺 |
|---|---|
| 中文同义词 | (3AR,8AR)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二恶唑并[4,5-E][1,3,2]二噁磷杂庚英-6-基)二甲胺;(11AR) - (+) - 10,11,12,13-四氢-5-(1,1-二甲基乙基)二茚并[7,1-DE,1',7'-FG] [1.3.2]二氧磷杂环;(3AR,8AR)-N,N,2,2-四甲基4,4,8,8-四苯基四氢-[1,3]二氧杂环戊烯并[4,5-E][1,3,2]二氧磷杂七-6-胺;(3AR,8AR)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二噁唑并[4,5-E][1,3,2]二噁膦杂庚英-6-基)二甲胺;(3AR,8AR)-(-)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二唑并[4,5-E][1,3,2]二磷杂庚英-6-基)二甲基胺;(3AR,8AR)-(-)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二噁唑并[4,5-E][1,3,2]二噁磷杂庚英-6-基)二甲基胺;(3AR,8AR)-(2,2-DIMETHYL-4,4,8,8-TETRAPHENYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-E][1,3,2]DIOXAPHOSPHEPIN-6-YL)DIMETHYLAMINE(3AR,8AR)-(2,2-二;(3AR,8AR)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二噁唑并[4,5-E][1,3,2]二噁膦杂庚英-6-基)二甲胺 100MG |
| 英文名称 | (3AR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TETRAPHENYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-E][1,3,2]DIOXAPHOSPHEPIN-6-YL)DIMETHYLAMINE |
| 英文同义词 | (3AR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TETRAPHENYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-E][1,3,2]DIOXAPHOSPHEPIN-6-YL)DIMETHYLAMINE;(3aR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TET&;(3aR,8aR)-(-)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine,min.98%;(3aR,8aR)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine;(3aR,8aR)-(-)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine, min. 98%;(3aR,8aR)-(-)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5- e][1,3,2]dioxaphosphepin-6-yl)dimethylamine, min. 98%;(3AR,8aR)-N,N,2,2-Tetramethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosph;(11aR)-(+)-10,11,12,13-Tetrahydro-5-(1,1-diMethylethyl)diindeno[7,1-de,1',7'-fg)[1.3.2] dioxaphosphocin, 97% (R)-FuP-tBu |
| CAS号 | 213843-90-4 |
| 分子式 | C33H34NO4P |
| 分子量 | 539.6 |
| EINECS号 | |
| 相关类别 | 膦配体;有机配体;试剂;Phosphoramidite;Chiral Catalysts, Ligands, and Reagents;DSM MonoPhos Phosphoramidites;Privileged Ligands and Complexes;TADDOL Phos;Chiral Phosphine;CPN |
| Mol文件 | 213843-90-4.mol |
| 结构式 | ![(3AR,8AR)-(-)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二氧并[4,5-E][1,3,2]二氧磷-6-YL)二甲胺 结构式](CAS/GIF/213843-90-4.gif) |
(3AR,8AR)-(-)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二氧并[4,5-E][1,3,2]二氧磷-6-YL)二甲胺 性质
| 熔点 | 218-221 °C |
|---|---|
| 比旋光度 | -159° (c 1.66, CHCl3) |
| 沸点 | 569.8±50.0 °C(Predicted) |
| 储存条件 | under inert gas (nitrogen or Argon) at 2-8°C |
| 酸度系数(pKa) | 2.44±0.70(Predicted) |
| 形态 | 粉末 |
| 颜色 | 白色 |
| 敏感性 | moisture sensitive |
| InChIKey | DRPNADVMTMEWQY-LOYHVIPDSA-N |
| SMILES | CN(C)P1OC([C@@H]2OC(C)(C)O[C@H]2C(O1)(c3ccccc3)c4ccccc4)(c5ccccc5)c6ccccc6 |
安全信息
| WGK Germany | 3 |
|---|---|
| 存储类别 | 11 - 可燃固体 |
| 提供商 | 语言 |
|---|---|
|
英文
|
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2026/06/05 | XW0221384390403 | 试剂(R,R)-TADDOL-PNMe2 (R,R)-TADDOL-PNMe2 | 213843-90-4 | 1g | 1376元 |
| 2026/06/05 | XW0221384390402 | 试剂(R,R)-TADDOL-PNMe2 (R,R)-TADDOL-PNMe2 | 250mg | 345元 |